We integrated expression profiles with bioinformatics analyses of miRNA and TF regulatory programs to identify candidate miRNAs involved with cardiac development. Expression profiling showed that miR-200c, which is not normally detected in adult heart, is progressively down-regulated both during cardiac development and in vitro differentiation of human embryonic stem cells (hESCs) to cardiomyocytes (CMs). We employed computational methodologies to predict target genes of both miR-200c and five key cardiac TFs to identify co-regulated gene networks. The inferred cardiac networks revealed that the cooperative action of miR-200c with these five key TFs, including three (GATA4, SRF and TBX5) targeted by miR-200c, should modulate key processes and pathways necessary for CM development and function. Experimentally, over-expression (OE) of miR-200c in hESC-CMs reduced the mRNA levels of GATA4, SRF and TBX5. Cardiac expression of Ca 2þ , K þ and Na 
.. Conclusions
Our analyses demonstrate that miR-200c represses hESC-CM differentiation and maturation. The integrative computation and experimental approaches described here, when applied more broadly, will enhance our understanding of the interplays between miRNAs and TFs in controlling cardiac development and disease processes.
Introduction
Complex interactions among gene expression, cell signaling and regulatory pathways are required for proper development of a four chambered heart with functional cardiomyocytes (CMs). 1, 2 Integral to these interactions are microRNAs (miRNAs), non-encoding RNAs of $22 nucleotides, that function as negative transcriptional regulators through degradation or inhibition by RNA interference. In heart, a number of regulatory miRNAs have already been described that are developmentally important. [3] [4] [5] [6] miR-499, for example, promotes ventricular specification, 7 while miR-208a acts as a regulator of cardiac hypertrophy and conduction in mice. 8 miR-208 and -499 regulate myosin expression by controlling the activity of downstream targets like Thrap1 and transcriptional repressors of Myh7. 9 Using in vitro differentiation models of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), miR-1 was found to promote and regulate CM differentiation, and it facilitates the electrophysiological maturation of hESC-CMs. 7 Developmentally, myocyte enhancer factor-2 (MEF2) and serum response factor (SRF) directly regulate cardiac transcription of miR-1/ miR-133a pairs, 10 whereas over-expression (OE) of miR-17-92 downregulates the expression of Isl1 and Tbx1 in mouse embryos. 11 Moreover, introduction of GATA4 and TBX5 with miR-1 and -133 into human fibroblasts trans-differentiates these cells into CMs 12 or cardiaclike myocytes. 13 Despite extensive research showing that transcription factors (TFs) and miRNAs cooperate to regulate heart development and myocyte function, 3, 5, 6 miRNA-mediated regulatory activities and interactions with transcriptional regulators in human remain poorly defined. To predict TF or miRNA target genes, bioinformatic algorithms or approaches have been developed that integrate multi-type omics data. Examples include Bayesian model, 14 regression model 15 and matrix decomposition or projection. 16, 17 The quantitative relationships derived from these algorithms allow one to infer transcriptional regulatory networks that are useful for identifying key regulatory components.
In the present study, we have built upon these approaches to test the hypothesis that miRNAs present in hESCs and downregulated with differentiation could act through inhibition of procardiomyogenic factors. By combining transcriptomic profiling, bioinformatics modeling with experimental testing, we postulated that we could uncover the effects of these regulatory miRNAs on cardiac development using in vitro differentiated hESC-CMs. Using publicly available datasets, we found that miR-200c is progressively down-regulated both during hESC-CM differentiation and heart development. We then employed computational methods to identify target genes co-regulated by miR-200c and five previously described cardiac TFs (GATA4, SRF, TBX5, HAND1 and NKX2.5) known to be essential for CM differentiation and function. hESCs were maintained in E8 media (Thermo Fisher). Differentiation was induced using a modified monolayer system in RPMI/B27 medium lacking insulin (Thermo Fisher), by the addition of CHIR99021 (6 lM; Selleckchem, Houston, TX, USA), from Days 0 to 2, followed by the addition of IWR-1 (10 lM; Sigma-Aldrich) from Days 3 to 5. 19, 20 CMs were maintained in RPMI/B27 medium containing insulin from Day 7 (Thermo Fisher). Beating was usually observed on Days 7 and 8.
Lentivirus-mediated gene transfer
HES2 and H7 hESC-CMs were isolated enzymatically, plated as single cells on Matrigel-coated surfaces and cultured at 37 C and 5% CO 2 in 5% fetal bovine serum (FBS)/dulbecco's modified eagle medium (DMEM) for the HES2-CMs, or in RPMI/B27 medium containing insulin for the H7-CMs. For miRNA over-expression, lentivirus (LV)-CMVmiR200c-EF1a-GFP (also called LV-miR-200c; System Biosciences; prepared by the Stem Cell and Regenerative Medicine Consortium Core) at a multiplicity of infection (MOI) of $3 was applied overnight. The culture medium was replaced the following day. Positively transduced cells were identified by green fluorescent protein (GFP) expression and used for experiments at 3-7 days after transduction. For the controls, hESC-CMs were transduced with LV-CMV-BLANK-EF1a-GFP, which lacked any miRNA coding sequence, as designed and recommended by System Biosciences. For knockdown (KD) experiments, LV-H1-miR200cZip-CMV-GMP (also called LV-miR-200c-zip) was used. Control cells were transduced with LV-H1-scrambleZip-CMV-GFP, according to manufacturer's instructions.
mRNA quantitative real-time PCR
Total RNA was extracted using RNeasy Plus with gDNA elimination (Qiagen, Germantown, MD, USA), according to the manufacturer's miR-200c is a novel cardiomyocyte repressor protocol. Reverse transcription was performed with the QuantiTect Reverse Transcription Kit (Qiagen). Quantitative real-time PCR (qRT-PCR) was carried out using the KAPA SYBR V R FAST qPCR Kit Master Mix (KAPA Biosystems, Wilmington, MA, USA) and StepOne Plus (BioRad, Hercules, CA, USA), according to the manufacturer's instructions. Samples were run in triplicate for each independent biological sample. The primer sequences are available upon request. Gene transcript abundance was normalized to GAPDH and then to that of the control sample to control for biological variations among the different sets of samples.
miRNA qRT-PCR
To validate miRNA OE in transduced cells, reverse transcription was performed with the miRscript kit (Qiagen). qRT-PCR was carried out as described earlier. The forward primer sequence was taken from the mature target miRNA sequence (TAATACTGCCGGGTAATGAT GGA) and the universal reverse primer was provided in the miRNA script kit. MiR-188 was used as the endogenous control because it displayed the most stable expression profile across many cell types. 7 
Immunofluorescence staining
On Days 20-30, CM cultures were dissociated and plated onto Matrigelcoated glass coverslips in DMEM supplemented with either 5% fetal bovine serum, 100 lM nonessential amino acids and 2 mM glutamine for the HES2-CMs, or B27/RPMI media for the H7-CMs. Cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at room temperature (RT), after which time they were washed with PBS. The cells were permeabilized in PBS containing 0.1% Triton X-100 for 10 min at RT and blocked with 10% normal goat serum for 1 h at RT. Following incubation with anti-a1C antibody (Abcam, Cambridge, UK) diluted to 1:100 with 1% BSA at 4 C overnight and washing, Alexa Fluor 555 goat anti-mouse IgG (Thermo Fisher) was applied for 1 h at RT in the dark. The coverslips containing the cells were mounted onto glass slides under Prolong Gold mounting medium (Thermo Fisher). Samples were imaged with a Nikon Eclipse TiS microscope (Nikon Instruments Inc., Japan). Data were analyzed with Image J (NIH, http://imagej.nih.gov/ij/). miRNA Mimics represent mature miRNAs that enable regulation of mRNA through partial complementarity to target sites in the 3 0 UTR of a specific sequence. All luciferase assays were performed 24 h after transfection according to the manufacturer's instructions (Promega Corporation). Luciferase activities with five replicates were measured using a spectrophotometer (Thermo Fisher). The Firefly luciferase activity was normalized against the Renilla luciferase activity.
Western blotting

Ca 2þ influx measurements
Human ESC-CMs were transduced with either GFP-(control) or LVmiR-200c virus 3-6 days before Ca 2þ measurements. Just prior to the start of Ca 2þ imaging, cells were loaded with xRhod-1AM (2 mM) for 30 min at RT. Cells were washed twice with Hanks' balanced salt solution (HBSS) and then incubated in HBSS for another 10 min to deesterify the dye. Fluorescence images were acquired every 2 s using an Epi-fluorescence Live Imaging System (Nikon, Japan) with a 20Â/ 0.45 NA Plan Fluor Dry objective lens. GFP and xRhod-1 fluorescence were visualized using 480 nm excitation/510 nm emission and 540 nm excitation/605 nm emission, respectively. In some experiments, 20 mM (±)-Bay K8644 (Sigma-Aldrich) was added to the cells 2 min after the start of data acquisition. Data were analyzed with Image J.
Calcium imaging
Human ESC-CMs were loaded with Fluo-4/AM (5 lM; Thermo Fisher) for 30 min in the dark at 37 C. Fluo-4 was excited at 488 nm line and captured at wavelengths 505-530 nm. Data acquisition was performed using a confocal microscope (Olympus FV1000, Olympus, Japan). Ca 
Statistical analysis
We calculated P-values using an R package 'phyper' to evaluate whether the predicted target genes of miRNAs or TFs were significantly enriched among a category of biological functions. The enrichment statistical analysis was described in the Supplemental methods. A student's t-test was employed to determine statistical significance between all experimental groups, except for the differences in full nested ANOVA was performed using R package. Results are presented as mean ± SEM (standard error of the mean), with n values indicated in the text. The asterisks indicate data that are significantly different at P < 0.05 (*) and P < 0.01 (**).
Results
miR-200c is down-regulated with time of differentiation and developmental stage
To identify inhibitory miRNAs of cardiomyogenesis, we analyzed three publicly available microarray (GSE35672 and Wilson et al.
21
) and miRNA-seq (GSE62913) datasets that describe CM differentiation and development (see Supplemental methods). Among the 188 miRNAs that were identified (see Supplementary material online, Table S1 ), only three miRNAs (miR-200c, -373 and -106a-5p) and 11 miRNAs present in three and two datasets, respectively, were down-regulated ( Figure 1A) .
As a complementary approach, we grouped and analyzed all the data (see Supplemental methods) to identify three clusters of 25, 15 and 15 miRNAs that were significantly reduced as a function of heart development ( Figure 1B) , in vitro differentiation of hESC-CM ( Figure 1C ) and with prolonged cultures of in vitro differentiated hiPSC-CM ( Figure 1D ), respectively. Only miR-200c was present in all three clusters.
We searched two miRNA target databases, mirTarbase and miRecords (Supplemental methods) to identify potential targets of the 43 down-regulated miRNAs shown in Figure 1A -D. Among these miRNAs, miR-200c was predicted to bind seven cardiac and pluripotency TFs (GATA4, TBX5, KLF4, IRF4, SOX2, SRF and ZEB1; Table 1 ). We then examined putative miRNA binding targets related to heart development and function based on gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) functional categories (i.e. 'heart genes'). Of the miRNAs examined, miR-200c was predicted to target the largest number of the heart genes (see Supplementary material online, Table S2 ), including a variety of ion channels (CACNA1C, Table S3 ).
We calculated P-values to evaluate whether targets of the 43 miRNAs were significantly enriched among heart genes. As shown in Table 1 and see Supplementary material online, Table S2 , the heart targets of miR-200c were significantly enriched with the lowest P-value 1.28 Â 10 -7 among all the miRNAs tested. These data suggested a close relationship between miR-200c binding targets and heart development. Five members of the miR-200 family have been described, including miR-200a, -200b, -200c, -429 and -141. The expression pattern of all five members decreased with hESC-CM differentiation; however, only miR200c was highly abundant in undifferentiated hESCs and down-regulated in all three reference datasets (see Supplementary material online, Figure  S1 ). Cardiac TFs SRF, HAND1, TBX5 and GATA6 were predicted to bind to miR-200c promoter. In contrast, miR-200a and -200b promoters only contain putative binding sites for a few cardiac or pluripotency TFs (see Supplementary material online, Figure S4 ). MiR-200c was therefore postulated to be a miRNA with potential regulatory functions during cardiac development.
Comparison of methods for identifying target genes of miR-200c and cardiac TFs
We analyzed two mRNA microarray datasets (GSE50704 and GSE17579) that covered four stages of hESC-derived CM differentiation and heart development (see Supplemental methods). Four computational methods PTHGRN 15 and regulatory component analysis (RCA) 17 with network component analysis (NCA) 16 and fast network component analysis (fastNCA) 22 were utilized to predict target genes of miR-200c
and of five cardiac TFs (GATA4, HAND1, NKX2-5, SRF and TBX5; see Supplementary material online, Table S4 ). Enrichment statistical analysis outputs with low P-values were enriched for predicted target genes that could be functionally categorized using GO biological processes. Figure 2A shows the lowest p values for miR-200c and three TF (GATA4, SRF and TBX5) target genes predicted by PTHGRN using GSE50704 dataset. Computationally, these P-values were lower than those generated by the other three methods. Overall, PTHGRN gave the lowest average P-values for all six regulators. Using another GSE17579 dataset, PTHGRN obtained a higher enrichment of biological processes when compared to other three methods ( Figure 2B ). This comparative analysis suggests that PTHGRN reliably predicted biologically meaningful target genes of both miR-200c and key TFs. Next, we independently evaluated the performance of the algorithms to assess the up-regulated heart target genes using statistical enrichment analysis (see Supplemental methods). This subset was chosen, because the vast majority of heart target genes with altered expression were, in fact, increased in abundance (see Supplementary material online, Table  S4 ). We determined the enrichment P-values for all of the predicted upregulated genes in the genome. The P-values of the heart target genes of miR-200c and TFs predicted by PTHGRN were the lowest among the four methods. Compared to the other three methods, PTHGRN proved to be statistically the most robust method for identifying heart target genes from expression datasets ( Table 2 ).
miR-200c and key cardiac TFs jointly regulate cardiac gene programs
From the PTHGRN analyses, we identified 127 and 131 target genes of miR-200c, respectively, from two microarray datasets ( Figure 3A and B) . 
GATA4)
were reported in mirTarbase. Among the TF target genes, 13 heart target genes of GATA4 have been validated (see Supplementary material online, Table S5 ). These results suggest that GATA4 can be coregulated by miR-200c, GATA4, HAND1, NKX2-5 and SRF. In addition, these analyses correctly identified six target genes of SRF or TBX5, including NKX2-5, MEF2C, GATA4, TNNT2, NPPA and MYH6. As shown in Figure 3C , these validated results highlight the direct or indirect cooperation of miR-200c with the key cardiac TFs in modulating downstream cardiac gene programs. The majority of genes in the network are coregulated by cardiac TFs present in Groups 1 and 2; however, miR-200c only directly binds to TFs in Group 1 and to $25% of the target genes ( Figure 3C ). The primary effects of miR-200c on cardiac development are therefore most likely mediated through post-transcriptional modulation of cardiac TFs.
Experimental validation of miR-200c target genes
To demonstrate the importance of miR-200c in CM differentiation, we tested whether cardiac gene transcripts can be increased in hESC-CMs via miR-200c KD using the lentiviral LV-miR-200c-zip system. Since LVmiR-200c-zip works by inhibition and does not necessarily decrease significantly miR-200c abundance, it was not possible to meaningfully quantify miR-200c levels following KD. We therefore validated our system by analyzing the miR-200c target gene ZEB1, whose expression would be increased when miR-200c is decreased (or decreased when miR-200c is increased). In these experiments (n = 6), KD of miR-200c significantly increased the mRNA of ZEB1 by 2.27-fold ( Figure 4A ). It also led to an increase in the mRNA levels of miR-200c predicted target Figure S3 -A) and resulted in a 2.38-fold decrease in ZEB1 mRNA relative to the control ( Figure 4B) . Similarly for other genes with predicted miR-200c binding sites, we observed a significant decrease in transcripts for TFs encoding GATA4, SRF and TBX5, as well as other known (ACVR2B) or predicted (PPARGC1A, BIN1, CACNA1C and KCNJ2) target genes ( Figure 4B ). In contrast, the expression of genes lacking predicted miR-200c binding sites, like the ubiquitous glucose transporter SLC4A1, and NKX2.5 were not significantly (P > 0.05) altered by OE (data not shown). However, some transcripts lacking miR-200c binding sites were reduced following miR-200c over-expression. Specific examples include HAND1 and KCNH2. Since these genes are likely regulated by Group 1 cardiac TFs GATA4/SRF/TBX5, respectively, the results suggest that the decrease in HAND1 and KCNH2 that was observed by miR200c OE may be due to indirect effects mediated by miR-200c targeted TFs. To demonstrate that our results are independent of the cell line or differentiation protocol utilized, we also transduced hESC H7-derived CMs (which were differentiated via modulation of the Wnt signaling pathway) with LV-miR-200c. The observed results indicate that the repression of the cardiac TFs and ion channel gene transcripts (see Supplementary material online, Figure S3 -B) were consistent with those seen with HES2 cells.
miR-200c impairs Ca 2þ channel activity in hESC-CMs
At the cellular level, the spontaneous beating frequency of differentiated CMs was increased significantly (Figure 5A) , showing that miR-200c OE not only altered transcript abundance of cardiac genes, but it also altered the functional properties of these cells. Among the putative miR-200c target genes, CACNA1C was an obvious candidate gene responsible for the altered beating frequency observed in the OE studies of miR-200c. This is because CACNA1C encodes the a1c subunit of the L-type Ca 2þ channel (LTCC) and mediates Ca 2þ influx essential for normal excitation-contraction coupling. 23, 24 Consistently, transcripts for CACNA1C were significantly altered by both KD and OE of miR-200c. By immunostaining, we observed reduced a1c protein staining in LV-miR200c transduced CMs compared to controls ( Figure 5B) . By western blotting, we observed a decrease of 11.3% in CACNA1C protein levels in miR-200c overexpressing hESC-CM ( Figure 5C ). These data suggest that CACNA1C could be regulated by miR-200c.
To determine if the predicted 3 0 UTR binding sites on CACNA1C were direct targets of miR-200c, we carried out Dual-Luciferase reporter assays in HEK293T cells. We cloned wt and mut forms of the 3 0 UTR sequence from CACNA1C, respectively ( Figure 5D ). Relative to Control (empty psiCHECK-2 reporter vector), use of the miRNA Mimics led to a decrease in overall luciferase activity (data not shown). When miR200c Mimics were introduced into HEK293T cells and compared with NC Mimics, a significant decrease in luciferase activity was observed with the wt sequences ( Figure 5E ). In contrast, no significant decrease in luciferase activity could be observed between the NC and miR-200c Mimics with the mut sequences. These results show that the 3 0 'UTR found in Figure S5 ). The Ca 2þ influx induced by Bay K8644, an agonist of LTCC, was significantly reduced in hESC-CMs where miR-200c was over-expressed ( Figure 6A) . Quantitatively, the plateau value was significantly decreased by $20% and the time to plateau (velocity) was increased by $30% (Figure 6B and C) . miR-200c thus represses CACNA1C RNA and protein, and functionally, this repression causes a decrease in overall LTCC-mediated Ca 2þ influx. Furthermore, we also observed that transduction with LV-miR-200c significantly increases the spontaneous calcium transient frequency while simultaneously decreasing the peak amplitude ( Figure 6D and 6G ). Both the upstroke and decay velocities were significantly reduced ( Figure 6E and 6F). These additional observations together with the increased beating frequency described earlier are consistent with a cellular phenotype that is usually only observed in very early, immature hESC-CMs.
Discussion
In this study, we performed an integrative analysis to study CM differentiation and maturation by constructing a transcriptomics and bioinformatics pipeline that integrates miRNA post-transcriptional with cooperative TF control mechanisms. For this, we adapted our previously published PTHGRN algorithm to infer miRNA and selected TF regulatory associations between genes and TFs or miRNAs The P-value was calculated based on hypergeometric distribution that evaluated whether the up-regulated targets of miR200c and five TFs are significantly enriched among the gene set related to heart development and function.
. methods, previously published results and through comparisons between independent transcriptome datasets. Statistically, the output was also more biologically meaningful because it provided a better functional enrichment of all target genes than the other approaches tested ( Figure 2 and Table 2 ). Using this approach, we identified a set of target genes for miR-200c and cardiac TFs that were in agreement with published results. Based on substantial experimental validation and function testing (Figures 4-6 and Supplementary material online, Figure S3 ), we demonstrated an important inhibitory role of miR-200c on human cardiac development, in the regulation of cardiac TFs and in the function of ion channels.
Interactions between miRNAs and TFs are documented mechanisms that control gene regulation during cell development and disease progression. Schlesinger et al., 25 for example, incorporated ChIP-seq binding of cardiac TFs (Gata4, Mef2a, Nkx2.5 and Srf) with mRNA and miRNA expression profiles of the mouse CM cell line HL-1 to define the combinatorial contribution of TFs and miRNAs to the modulation of cardiac maturation in mouse. These results, however, were not functionally Table S5 ). Triangle nodes in dark blue and light blue correspond to TF Groups 1 and 2, respectively. Oval nodes refer to target genes involved in various cardiac biological processes: Orange-heart development; Purple-cardiac regulators; Pink-contraction; Yellow-Ca 2þ handling; and Light green -K þ channel activity.
miR-200c is a novel cardiomyocyte repressor Figure S4-A) . Specifically, both miR-200b and miR-200c are predicted to bind to GATA4, SRF and TBX5, as well as to ion channel genes CACNA1C, KCNJ2 and SCN5A. Therefore, we speculate that these two miRNAs might have similar interactions with cardiac TFs (such as GATA4, which have been experimentally reported as their target 26, 27 ). Further studies determining whether miR-200b or miR-429 might play a similar function as miR-200c should help to clarify the similarities and differences in their interaction with these cardiac TFs.
Ion (Ca 2þ , K þ and Na þ ) channel activities and spatial localization are critical to promote electrophysiological development and maturation of CMs. Specifically, Ca 2þ influx mediated by LTCCs is required for the development of the embryonic heart, cardiac differentiation of pluripotent stem cells and the initiation of cardiac excitability and excitation-contraction coupling. [28] [29] [30] [31] In this study, we demonstrate that miR-200c can bind to the CACNA1C 3'UTR, and when miR-200c is overexpressed, the RNA, protein and Ca 2þ influx associated with CACNA1C/ a1c are repressed. Moreover, amphiphysin 2 (encoded by BIN1), which mediates T-tubule biogenesis and localizes the LTCC to T-tubules ( Figure  4B and literature 32, 33 ), is initially low in these cells, but it increases with time of cultivation. 34 Since BIN1 is shown to be target of miR-200c, it is likely that this inverse relationship is functionally significant on CM maturation. The regulated control of CACNA1C, BIN1 and other potential gene products by miR-200c may, therefore, directly contribute to the immature Ca 2þ handling properties observed in early hESC-CMs and following OE of miR-200c in later stage hESC-CMs (see Figure 6 ). Mutations in CACNA1C lead to arrhythmias and are implicated in both Timothy 35 and Brugada syndromes 36 in humans. Specifically, loss-of-function mutations of CACNA1C are associated with a short QT interval, 36 and this finding is in agreement with the increased beat frequency and a1c inhibition following miR-200c OE ( Figure 6 ). These data lead us to conclude that high levels of miR-200c negatively regulate the expression of genes involved in the development of a robust calcium handling system. 37, 38 Finally, transcripts of KCNH2 and KCNJ2 (both K þ channels) and SCN5A (Na þ channel) were altered by miR-200c OE or KD ( Figure 4B ). Thus, miR-200c likely controls the availability of ion channels important for different phases of cardiac action potentials, raising the possibility that aberrant levels of miR-200c are arrhythmogenic. Given the importance of the regulation of CACNA1C/ a1c and other ion channels by miR-200c binding, changes in miR-200c expression or mutations in miR-200c might also be associated with the development of human cardiac diseases. Our integrated transcriptomic, bioinformatics and functional analyses suggest that a combinatorial interplay between miR-200c and cardiac TFs is necessary to control transcriptional gene programs in cardiac development and differentiation. Based on these findings, we propose a model, whereby miR-200c negatively regulates cardiac development via two distinct mechanisms ( Figure 7) . First, it acts alone to directly inhibit translation of ion channels and TFs. Second, miR-200c forms regulatory modules either directly or indirectly with cardiac TFs, to coordinate diverse gene programs associated with heart developmental processes and function. This is supported by computational identification of a cardiac gene regulatory network and experimental validation of selected target genes. In conclusion, this approach has allowed us to demonstrate that miR-200c is a novel repressor of hESC-CM differentiation and maturation. We provide mechanistic insights into its mode of action, and we provide a framework for further experimental investigation of miR200c-mediated cardiomyogenesis in vivo as well as its involvement in heart disorders. Inhibition of miR-200c may also be a novel approach to promote the maturation of Ca 2þ handling in hESC-CMs. Use of this combinatorial approach to evaluate the cooperation among miRNAs and TFs should, therefore, lead to other findings that will improve our understanding of cardiac development and potentially to improved understanding of heart disease.
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